Velphoro 500 MG chewable tab 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FW44G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,610
Award facts
- Contract value 100% obligated
- $48,609.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency (DLA) on January 22, 2026, for the supply of Velphoro 500 mg chewable tablets (90-count units) with a ceiling value of approximately $48.6K. This firm fixed-price delivery order, which is scheduled for completion by January 23, 2026, was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Velphoro is a phosphate binder medication primarily used to treat hyperphosphatemia in patients with chronic kidney disease, representing the type of specialized pharmaceutical commodity critical to military and veteran healthcare systems.
This delivery order is issued under Amerisourcebergen's parent company Cencora's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9M through December 2031. This primary contract vehicle enables the pharmaceutical distributor to supply a comprehensive range of medical products—including specialty medications, generic and brand-name drugs, vaccines, and medical supplies—to support military healthcare programs globally. The contract reflects Cencora's role as a critical vendor within the federal medical supply chain, serving defense health agencies and other government healthcare systems through a flexible procurement mechanism that accommodates both routine and specialized pharmaceutical needs.
Quick answers
Who was awarded contract SPE2DR26FW44G?
SPE2DR26FW44G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FW44G worth?
The government has obligated $48,610 on SPE2DR26FW44G.
Is contract SPE2DR26FW44G an order under another contract?
Yes. SPE2DR26FW44G is a delivery order under SPE2DR25D3011, an indefinite delivery contract.
Was contract SPE2DR26FW44G competed?
The extent of competition for SPE2DR26FW44G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award